Cargando…

Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma

The activation of the stimulating factor of the interferon gene (STING) pathway can enhance the immune response within the tumor. Cyclic diguanylate monophosphate (c-di-GMP) is a negatively charged, hydrophilic STING agonist, however, its effectiveness is limited due to the poor membrane permeabilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ziyuan, Liu, Juan, Xiao, Min, Zhang, Quanfeng, Liu, Zhonghua, Liu, Meiyan, Zhang, Peng, Zeng, Youlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tsinghua University Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643898/ https://www.ncbi.nlm.nih.gov/pubmed/36405984 http://dx.doi.org/10.1007/s12274-022-5102-z

Ejemplares similares

Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues
por: Yanase, Yuta, et al.
Publicado: (2022)

STING is a direct innate immune sensor of cyclic-di-GMP
por: Burdette, Dara L., et al.
Publicado: (2011)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

Cu(BF(4))(2)/AC-Catalyzed Synthesis of N-Substituted Anilines, N-Substituted 1,6-Naphthyridin-5(6H)-one, and Isoquinolin-1(2H)-one
por: Wu, Shuang, et al.
Publicado: (2022)

Structure of STING bound to c-di-GMP Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System
por: Shu, Chang, et al.
Publicado: (2012)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
por: Su, Ting, et al.
Publicado: (2022)

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
por: Wu, You-tong, et al.
Publicado: (2022)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

Fatty Acid Modification of the Anticancer Peptide LVTX-9 to Enhance Its Cytotoxicity against Malignant Melanoma Cells
por: Li, Fengjiao, et al.
Publicado: (2021)

STING activation in cancer immunotherapy
por: Su, Ting, et al.
Publicado: (2019)

Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy
por: Li, Lin, et al.
Publicado: (2023)

Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
por: Zhang, Hai-Nan, et al.
Publicado: (2017)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
por: Huang, Cuiqing, et al.
Publicado: (2023)

Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy
por: Wang, Bin, et al.
Publicado: (2022)

Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy
por: Zhou, Ying, et al.
Publicado: (2022)

Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy
por: Shae, Daniel, et al.
Publicado: (2019)

Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
por: Zheng, Huan, et al.
Publicado: (2022)

STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy
por: Zhou, Lei, et al.
Publicado: (2023)

STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
por: Nakamura, Takashi, et al.
Publicado: (2021)

Identification and Characterization of c-di-GMP Metabolic Enzymes of Leptospira interrogans and c-di-GMP Fluctuations After Thermal Shift and Infection
por: Xiao, Guohui, et al.
Publicado: (2018)

Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation
por: Cavagnero, Kellen J., et al.
Publicado: (2021)

Nitric oxide regulated cyclic di-GMP signaling
por: Boon, Elizabeth M, et al.
Publicado: (2013)

Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS–STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy
por: Dong, Wenpei, et al.
Publicado: (2023)

Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria
por: Valentini, Martina, et al.
Publicado: (2016)

STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
por: Messaoud-Nacer, Yasmine, et al.
Publicado: (2022)

Intercepting second-messenger signaling by rationally designed peptides sequestering c-di-GMP
por: Hee, Chee-Seng, et al.
Publicado: (2020)

Identification of the core c-di-GMP turnover proteins responsible for root colonization of Bacillus velezensis
por: Dong, Xiaoyan, et al.
Publicado: (2022)

Pleiotropic Effects of c-di-GMP Content in Pseudomonas syringae
por: Wang, Tingting, et al.
Publicado: (2019)

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
por: Corrales, Leticia, et al.
Publicado: (2013)

c-di-GMP inhibits the DNA binding activity of H-NS in Salmonella
por: Li, Shuyu, et al.
Publicado: (2023)

Polarity of c-di-GMP synthesis and degradation
por: Kreiling, Vanessa, et al.
Publicado: (2023)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy
por: Jiang, Xiaoyi, et al.
Publicado: (2022)

Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer
por: Zhang, Jibing, et al.
Publicado: (2023)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

OpaR Controls the Metabolism of c-di-GMP in Vibrio parahaemolyticus
por: Zhang, Yiquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbvg6rvf8b2bqtr4osqv3lrsp7